Senior insider sale
ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$27.9K
1.07K shares
What this filing means
CURRAN TERRIE plans to sell 1.07K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $27.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/20/2026ACC: 0001628280-26-058275
Director
Since Nov 2020
1.07K
Shares to sell
$27.9K
Approx. market value
1.07K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
5/31/2023
1.07KTotal acquired1.07K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/31/2023 | Stock Option Exercise Cash | 1.07K | — |
| Total | 1.07K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.07K
Market value
$27.9K
8/20/2026
Total
Units
1.07K
Value
$27.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/20/2026 | 1.07K | $27.9K | NASDAQ | Planned |
| Total | 1.07K | $27.9K | ||